Table of Contents Author Guidelines Submit a Manuscript
Journal of Biomedicine and Biotechnology
Volume 2006, Article ID 43181, 5 pages
http://dx.doi.org/10.1155/JBB/2006/43181
Research Article

Evidence of a Genomic Biomarker in Normal Human Epithelial Mammary Cell Line, MCF-10A, That Is Absent in the Human Breast Cancer Cell Line, MCF-7

Department of Biological Sciences, Clark Atlanta University, 223 James P Brawley Drive, Atlanta, GA 30314, USA

Received 21 November 2005; Accepted 5 April 2006

Copyright © 2006 Brian H. Crawford et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. P C Watkins, “Restriction fragment length polymorphism (RFLP): applications in human chromosome mapping and genetic disease research,” BioTechniques, vol. 6, no. 4, pp. 310–322, 1988. View at Google Scholar
  2. H Donis-Keller, P Green, C Helms et al., “A genetic linkage map of the human genome,” Cell, vol. 51, no. 2, pp. 319–337, 1987. View at Publisher · View at Google Scholar
  3. U Landegren, R Kaiser, C T Caskey, and L Hood, “DNA diagnostics: molecular techniques and automation,” Science, vol. 241, no. 4876, pp. 229–237, 1988. View at Publisher · View at Google Scholar
  4. G Caetano-Anollés, B J Bassam, and P M Gresshoff, “DNA amplification fingerprinting using very short arbitrary oligonucleotide primers,” BioTechnology, vol. 9, no. 6, pp. 553–557, 1991. View at Google Scholar
  5. E M Golenberg, D E Giannasi, M T Clegg et al., “Chloroplast DNA sequence from a Miocene Magnolia species,” Nature, vol. 344, no. 6267, pp. 656–658, 1990. View at Publisher · View at Google Scholar
  6. E Hagelberg, I C Gray, and A J Jeffreys, “Identification of the skeletal remains of a murder victim by DNA analysis,” Nature, vol. 352, no. 6334, pp. 427–429, 1991. View at Publisher · View at Google Scholar
  7. F Kerangueven, T Noguchi, F Coulier et al., “Genome-wide search for loss of heterozygosity shows extensive genetic diversity of human breast carcinomas,” Cancer Research, vol. 57, no. 24, pp. 5469–5474, 1997. View at Google Scholar
  8. F Jiang, R Desper, C H Papadimitriou et al., “Construction of evolutionary tree models for renal cell carcinoma from comparative genomic hybridization data,” Cancer Research, vol. 60, no. 22, pp. 6503–6509, 2000. View at Google Scholar
  9. R A Gatenby and B R Frieden, “Application of information theory and extreme physical information to carcinogenesis,” Cancer Research, vol. 62, no. 13, pp. 3675–3684, 2002. View at Google Scholar
  10. V A Spencer, S K Samuel, and J R Davie, “Altered profiles in nuclear matrix proteins associated with DNA in situ during progression of breast cancer cells,” Cancer Research, vol. 61, no. 4, pp. 1362–1366, 2001. View at Google Scholar
  11. L H Kuller, “The etiology of breast cancer from epidemiology to prevention,” Public Health Reviews, vol. 23, no. 2, pp. 157–213, 1995. View at Google Scholar
  12. V L Ernster, J Barclay, K Kerlikowske, D Grady, and C Henderson, “Incidence of and treatment for ductal carcinoma in situ of the breast,” Journal of the American Medical Association, vol. 275, no. 12, pp. 913–918, 1996. View at Publisher · View at Google Scholar
  13. W H Wen, L Bernstein, J Lescallett et al., “Comparison of TP53 mutations identified by oligonucleotide microarray and conventional DNA sequence analysis,” Cancer Research, vol. 60, no. 10, pp. 2716–2722, 2000. View at Google Scholar
  14. R GH Cotton, “Slowly but surely towards better scanning for mutations,” Trends in Genetics, vol. 13, no. 2, pp. 43–46, 1997. View at Publisher · View at Google Scholar
  15. B J Bassam, G Caetano-Anollés, and P M Gresshoff, “Fast and sensitive silver staining of DNA in polyacrylamide gels,” Analytical Biochemistry, vol. 196, no. 1, pp. 80–83, 1991. View at Publisher · View at Google Scholar
  16. C Osborne, P Wilson, and D Tripathy, “Oncogenes and tumor suppressor genes in breast cancer: potential diagnostic and therapeutic applications,” The Oncologist, vol. 9, no. 4, pp. 361–377, 2004. View at Publisher · View at Google Scholar
  17. F M Waldman, S DeVries, K L Chew, D H II Moore, K Kerlikowske, and B-M Ljung, “Chromosomal alterations in ductal carcinomas in situ and their in situ recurrences,” Journal of the National Cancer Institute, vol. 92, no. 4, pp. 313–320, 2000. View at Publisher · View at Google Scholar
  18. P O'Connell, V Pekkel, S AW Fuqua, C K Osborne, G M Clark, and D C Allred, “Analysis of loss of heterozygosity in 399 premalignant breast lesions at 15 genetic loci,” Journal of the National Cancer Institute, vol. 90, no. 9, pp. 697–703, 1998. View at Google Scholar
  19. J GK Williams, A R Kubelik, K J Livak, J A Rafalski, and S V Tingey, “DNA polymorphisms amplified by arbitrary primers are useful as genetic markers,” Nucleic Acids Research, vol. 18, no. 22, pp. 6531–6535, 1990. View at Publisher · View at Google Scholar
  20. K V Wood, “Recent advances and prospects for use of beetle luciferases as genetic reporters,” in Bioluminescence and Chemiluminescence: Current Status, P Stanley and L Kricka, Eds., pp. 543–546, John Wiley & Sons, Chichester, UK, 1991. View at Google Scholar
  21. B J Quade, S Weremowicz, D M Neskey et al., “Fusion transcripts involving HMGA2 are not a common molecular mechanism in uterine leiomyomata with rearrangements in 12q15,” Cancer Research, vol. 63, no. 6, pp. 1351–1358, 2003. View at Google Scholar